Related Experiment Video
Updated: Sep 21, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Conformation changes in brain calcineurin in diabetic rats with or without treatment with vanadyl sulfate
Abstract:
Recent studies have shown that vanadium salts are able to reduce blood glucose in diabetics and overcome, to some degree, insulin resistance. This paradigm has been followed to monitor the effects of diabetes and vanadyl treatment on brain calcineurin (CN), an important protein phosphatase. Male rats were rendered diabetic by a single injection of streptozotocin (STZ), resulting in an elevation of blood glucose from 108 +/- 13 to >400 mg/dl. Diabetic animals were given vanadyl sulfate trihydrate (0.5 mg/dl.) in their drinking water for 3 weeks, which led to a fall in blood glucose to 156 +/- 53 mg/ml. Brain CN activity (units/mg brain protein) in diabetic rats was 77% that of control animals, whereas vanadyl-treated diabetic animals were characterized by CN activities like that of controls. CN was purified from brains of control animals, STZ-induced diabetic animals, and STZ-induced diabetic animals receiving vanadyl, then spin-labeled with 3-maleimide-proxyl and studied via electron spin resonance spectroscopy. The rotational correlation time of CN from control animals and vanadyl-treated diabetic animals was 6.4 x 10(-11) s(-1), whereas that from STZ-induced-diabetic animals was 8 x 10(-11) s(-1). Thus, STZ-induced diabetes in rats results in an increase in the rotational correlation time of brain CN relative to control animals, yet vanadyl treatment of STZ-induced diabetic animals reduced the rotational correlation time to that of control. These data suggest that diabetes can lead to apparent conformational changes in brain CN; also, CN conformation in diabetic rats was restored by vanadyl treatment.
Insights
Vanadyl sulfate treatment effectively lowered blood glucose in diabetic rats and restored brain calcineurin (CN) activity and conformation. This suggests potential therapeutic benefits for diabetes-related neurological changes.
Area of Science:
- Biochemistry
- Neuroscience
- Endocrinology
Background:
- Vanadium salts show potential in reducing blood glucose and improving insulin resistance in diabetic individuals.
- Brain calcineurin (CN) is a crucial protein phosphatase implicated in various cellular functions.
Purpose of the Study:
- To investigate the impact of diabetes and vanadyl treatment on brain calcineurin (CN) activity and conformation.
- To assess the potential of vanadyl sulfate in mitigating diabetes-induced alterations in brain CN.
Main Methods:
- Diabetes was induced in male rats using streptozotocin (STZ).
- Diabetic rats received vanadyl sulfate trihydrate in their drinking water for three weeks.
- Brain CN activity was measured, and CN was purified, spin-labeled, and studied using electron spin resonance (ESR) spectroscopy.
Main Results:
- STZ-induced diabetes significantly elevated blood glucose levels and reduced brain CN activity to 77% of control levels.
- Vanadyl treatment normalized blood glucose levels and restored brain CN activity to control levels.
- ESR spectroscopy revealed increased rotational correlation time of CN in diabetic rats, indicating conformational changes, which was reversed by vanadyl treatment.
Conclusions:
- STZ-induced diabetes causes conformational changes in rat brain CN, evidenced by altered rotational correlation time.
- Vanadyl sulfate treatment effectively reverses these diabetes-induced conformational changes in brain CN.
- These findings suggest that vanadyl compounds may offer a therapeutic strategy for managing neurological complications associated with diabetes.
More Related Videos
08:55Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification
Published on: November 20, 2017
07:41Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020